1. Yasnoff WA, O'Carroll PW, Koo D, Linkins RW, Kilbourne E. Public health informatics: improving and transforming public health in the information age. J Public Health Manage Pract. 2000;6:67–75.
2. Public Health Functions Steering Committee. Public health in America. Statement adopted Fall 1994. Public Health Functions Web site. Available at: http://www.health.gov/phfunctions/public.htm. Accessed Jul 10, 2001.
3. Centers for Disease Control and Prevention. Ten great public health achievements—United States, 1900–1999. MMWR Morb Mortal Wkly Rep. 1999;48:241–3. [PubMed]
4. Centers for Disease Control and Prevention. Changes in the public health system. MMWR Morb Mortal Wkly Rep. 1999;48:1141–6.
5. Foster KR, Jenkins MF, Toogood AC. The Philadelphia yellow fever epidemic of 1793. Sci Am. 1998;279(2):88–93.
6. Institute of Medicine, Committee for the Study of the Future of Public Health, Division of Health Care Services. The Future of Public Health. Washington, DC: National Academy Press, 1988.
7. Centers for Disease Control and Prevention. Public Health Infrastructure: A Status Report. Prepared for the Appropriations Committee of the United States Senate, March 2001. Public Health Practice Program Office Web site. Available at: http://www.phppo.cdc.gov/documents/phireport2_16.pdf. Accessed Jun 6, 2001.
8. Gerzoff RB, Richards TB. The education of local health department top executives. J Public Health Manage Pract. 1997;3: 50–6.
9. Minnesota Department of Health. Selected Rural Public Health Agencies 2001 Wage and Benefit Survey. June 2001. Available at: http://www.health.state.mn.us/divs/chs/wagesurvey.doc. Accessed Jul 13, 2001.
10. Contract Agreement between Worthington Regional Hospital and the Minnesota Nurses Association, Jan 1, 2000–Dec 31, 2001. St. Paul, Minn.: Minnesota Nurses Association, 2001.
11. Minnesota Department of Health. Health Alert Network Year 2 Survey of Local Public Health Agencies [unpublished report]. Minneapolis, Minn.: MDH, March 2001.
12. Last JM (ed). A Dictionary of Epidemiology. New York: Oxford, 1995.
13. Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev. 1988:10:164–90. [PubMed]
14. Teutsch SM, Churchill RE (eds). Principles and Practice of Public Health Surveillance. New York: Oxford, 2000.
15. Koo D, Wetterhall SF. History and current status of the National Notifiable Diseases Surveillance System. J Public Health Manage Pract. 1996;2:4–10.
16. Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA. 1999;282:164–70. [PubMed]
17. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341:1509–19. [PubMed]
18. Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for the prevention of neural tube defect recurrences. Lancet. 1983;1:1027–31. [PubMed]
19. Medical Research Council. Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet. 1991;338;131–7. [PubMed]
20. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832–5. [PubMed]
21. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ. 1981;282:1509–11. [PMC free article] [PubMed]
22. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260:3141–5. [PubMed]
23. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262:2847–52. [PubMed]
24. Tolson GC, Barnes JM, Gay GA, Kowaleski JL. The 1989 revision of the US standard certificates and reports. Vital Health Stat , June 1991, no. 28:1–34. Washington, DC: Department of Health and Human Services, 1991. Publication PHS 91-1465.
25. Freedman MA, Gay GA, Brockert JE, Potrzebowski PW, Rothwell CJ. The 1989 revisions of the U.S. standard certificates of live birth and death and the U.S. standard report of fetal death. Am J Public Health. 1988;78:168–72. [PMC free article] [PubMed]
26. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LYC. Impact of folic acid fortification of the U.S. food supply on the occurrence of neural tube defects. JAMA. 2001;285: 2981–6. [PubMed]
27. Watkins ML, Edmonds L, McClearn A, Mullins L, Mulinare J, Khoury M. The surveillance of birth defects: the usefulness of the revised US standard birth certificates. Am J Public Health. 1996;86:731–4. [PMC free article] [PubMed]
28. Piper JM, Mitchel EF, Snowden M, Hall C, Adams M, Taylor P. Validation of the 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol. 1993;137:758–68. [PubMed]
29. Yen IH, Khoury MJ, Erickson JD, et al. The changing epidemiology of neural tube defects: United States, 1968–1989. Am J Dis Child. 1992;146:857–61. [PubMed]
30. Limb CJ, Homes LB. Anencephaly: changes in prenatal detection and birth status, 1972 through 1990. Am J Obstet Gynecol. 1994;170:1333–8. [PubMed]
31. National Birth Defects Prevention Network. Congenital malformations surveillance report: a report from the National Birth Defects Prevention Network. Teratology. 2000;61:33–85. [PubMed]
32. Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas–Mexico border, 1993–1995. Am J Epidemiol. 1999;149:1119–27. [PubMed]
33. Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects — 1983–1991: effectiveness in disease and injury prevention. MMWR Morb Mortal Wkly Rep. 1991;40:513–6. [PubMed]
34. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992;41 (RR–14):1–7.
35. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30:24–9. [PubMed]
36. U.S. Food and Drug Administration. 21 CFR Parts 136, 137, and 139. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register. 1996;61:8781–97.
37. Gregory JF III. Bioavailability of folate. Eur J Clin Nutr. 1997; 51(suppl):554–559. [PubMed]
38. Romano PS, Waitzman NJ, Scheffler RM, Pi RD. Folic acid fortification of grain: an economic analysis. Am J Public Health. 1995;85:667–676. [PMC free article] [PubMed]
39. Mills JL. Fortification of foods with folic acid: How much is enough? N Engl J Med. 2000;342:1442–5. [PubMed]
40. Centers for Disease Control and Prevention. Preventing Neural Tube Birth Defects: A Prevention Model and Resource Guide. Atlanta, GA: U.S. Department of Health and Human Services, CDC, National Center for Environmental Health, Division of Birth Defects and Pediatric Genetics, 1998. Available at: http://www.cdc.gov/ncbddd/folicacid/ntd/cover.htm .
41. Rader JI, Weaver CM, Angyal G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem. 2000;70:275–89.
42. Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age—United States, 1995 and 1998. MMWR. 1999;48:325–7. [PubMed]
43. March of Dimes/Gallup Organization. Folic acid and the prevention of birth defects: a national survey of pre-pregnancy awareness and behavior among women of childbearing age, 1995–2000 [survey]. White Plains, NY: March of Dimes, June 2000. Publication 31-1404-00.
44. Centers for Disease Control and Prevention. Folate status in women of childbearing age—United States, 1999. MMWR. 2000;49:962–5. [PubMed]
45. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449–54. [PubMed]
46. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification [letter]. Lancet. 1999;354: 915–6. [PubMed]
47. Marier R. The reporting of communicable diseases. Am J Epidemiol. 1977;105:587–90. [PubMed]
48. Alter MJ, Mares A, Hadler SC, et al. The effect of under reporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol. 1987;125:133–9. [PubMed]
49. Kirsch T, Shesser R. A survey of emergency department communicable disease reporting practices. J Emerg Med. 1991;9: 211–4. [PubMed]
50. Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians' knowledge of reporting requirements. Public Health Rep. 1984;99:31–5. [PMC free article] [PubMed]
51. Simpson DM. Improving the reporting of notifiable diseases in Texas: suggestions from an ad hoc committee of providers. J Public Health Manage Pract. 1996;2:37–9.
52. Campos-Outcalt D, England R, Porter B. Reporting of communicable diseases by university physicians. Public Health Rep. 1991;106:579–83. [PMC free article] [PubMed]
53. U.S. Department of Health and Human Services. 45 CFR parts 160 and 164. Standards for privacy of individually identifiable health information: final rule. Federal Register. 2000;65: 82798–829.